These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 9126384)

  • 1. Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins.
    Yamabhai M; Kay BK
    Anal Biochem; 1997 Apr; 247(1):143-51. PubMed ID: 9126384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
    Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of lysine-rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies.
    Rubini C; Ruzza P; Spaller MR; Siligardi G; Hussain R; Udugamasooriya DG; Bellanda M; Mammi S; Borgogno A; Calderan A; Cesaro L; Brunati AM; Donella-Deana A
    Biopolymers; 2010; 94(3):298-306. PubMed ID: 19921743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.
    Chan DC; Bedford MT; Leder P
    EMBO J; 1996 Mar; 15(5):1045-54. PubMed ID: 8605874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reexamination of the recognition preference of the specificity pocket of the Abl SH3 domain.
    Santamaria F; Wu Z; Boulègue C; Pál G; Lu W
    J Mol Recognit; 2003; 16(3):131-8. PubMed ID: 12833568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain.
    Pisabarro MT; Serrano L
    Biochemistry; 1996 Aug; 35(33):10634-40. PubMed ID: 8718852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins.
    Sparks AB; Hoffman NG; McConnell SJ; Fowlkes DM; Kay BK
    Nat Biotechnol; 1996 Jun; 14(6):741-4. PubMed ID: 9630982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family.
    Brannetti B; Via A; Cestra G; Cesareni G; Helmer-Citterich M
    J Mol Biol; 2000 Apr; 298(2):313-28. PubMed ID: 10764600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel peptide-SH3 interaction.
    Mongioví AM; Romano PR; Panni S; Mendoza M; Wong WT; Musacchio A; Cesareni G; Di Fiore PP
    EMBO J; 1999 Oct; 18(19):5300-9. PubMed ID: 10508163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-terminal SH3 domain of p67phox binds its natural ligand in a reverse orientation.
    Finan P; Koga H; Zvelebil MJ; Waterfield MD; Kellie S
    J Mol Biol; 1996 Aug; 261(2):173-80. PubMed ID: 8757285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of SH3 domain of Hck tyrosine kinase with cellular proteins containing proline-rich regions: evidence for modulation by unique domain.
    Gouri BS; Swarup G
    Indian J Biochem Biophys; 1997; 34(1-2):29-39. PubMed ID: 9343926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of Fyn-selective SH3 domain ligands via a combinatorial library strategy.
    Li H; Lawrence DS
    Chem Biol; 2005 Aug; 12(8):905-12. PubMed ID: 16125102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D; Superti-Furga G
    Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
    Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
    Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous assay of Src SH3 and SH2 domain binding using different wavelength fluorescence polarization probes.
    Lynch BA; Minor C; Loiacono KA; van Schravendijk MR; Ram MK; Sundaramoorthi R; Adams SE; Phillips T; Holt D; Rickles RJ; MacNeil IA
    Anal Biochem; 1999 Nov; 275(1):62-73. PubMed ID: 10542110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acan125 binding to the SH3 domain of acanthamoeba myosin-IC.
    Zot HG; Bhaskara V; Liu L
    Arch Biochem Biophys; 2000 Mar; 375(1):161-4. PubMed ID: 10683262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and specificity studies of small-molecule ligands for SH3 protein domains.
    Inglis SR; Stojkoski C; Branson KM; Cawthray JF; Fritz D; Wiadrowski E; Pyke SM; Booker GW
    J Med Chem; 2004 Oct; 47(22):5405-17. PubMed ID: 15481978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.